Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

about

Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies.

P2860

Q55284802-200CC591-9D49-4E9A-ADE2-4258AB4B46EE

P2860

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

Item

http://www.wikidata.org/entity/Q38635488

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

@en

type

Item

label

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

@en

prefLabel

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

@en

P1476

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis

@en

P2093

Carmelo Sterrantino

http://www.w3.org/2001/XMLSchema#string

Joaquim J Ferreira

http://www.w3.org/2001/XMLSchema#string

João Costa

http://www.w3.org/2001/XMLSchema#string

Marta M Duarte

http://www.w3.org/2001/XMLSchema#string

Márcio Barra

http://www.w3.org/2001/XMLSchema#string

Nilza Gonçalves

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.

Quantifying heterogeneity in a meta-analysis

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

GRADE guidelines: 3. Rating the quality of evidence

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

Sofosbuvir for previously untreated chronic hepatitis C infection

Meta-Analysis of Rare Binary Adverse Event Data.

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data.

P2888

s40264-017-0586-2

P304

77-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S40264-017-0586-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fausto Pinto

Daniel Caldeira

Filipe B. Rodrigues

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091085162

http://www.w3.org/2001/XMLSchema#string

P698

28786035

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

about

P2860

P2860

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921